Yuji Ikeda

2.4k total citations
79 papers, 1.4k citations indexed

About

Yuji Ikeda is a scholar working on Reproductive Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yuji Ikeda has authored 79 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Reproductive Medicine, 23 papers in Oncology and 22 papers in Molecular Biology. Recurrent topics in Yuji Ikeda's work include Ovarian cancer diagnosis and treatment (22 papers), Endometrial and Cervical Cancer Treatments (15 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Yuji Ikeda is often cited by papers focused on Ovarian cancer diagnosis and treatment (22 papers), Endometrial and Cervical Cancer Treatments (15 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Yuji Ikeda collaborates with scholars based in Japan, United States and Germany. Yuji Ikeda's co-authors include Katsutoshi Oda, Kei Kawana, Kosei Hasegawa, Jae‐Hyun Park, Keiichi Fujiwara, Taigo Kato, Tomoyuki Fujii, Kazuma Kiyotani, Yutaka Osuga and Kenbun Sone and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yuji Ikeda

75 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuji Ikeda Japan 22 554 447 337 278 247 79 1.4k
A.G.J. van der Zee Netherlands 24 593 1.1× 528 1.2× 210 0.6× 434 1.6× 251 1.0× 53 1.6k
Shulan Zhang China 25 851 1.5× 332 0.7× 457 1.4× 185 0.7× 358 1.4× 96 1.7k
Muh‐Hwa Yang Taiwan 16 465 0.8× 456 1.0× 186 0.6× 196 0.7× 245 1.0× 56 1.3k
Jesús González Bosquet United States 23 724 1.3× 392 0.9× 175 0.5× 530 1.9× 460 1.9× 100 1.9k
Eiichiro Tominaga Japan 24 648 1.2× 275 0.6× 119 0.4× 383 1.4× 481 1.9× 66 1.4k
Ilan Bruchim Israel 24 916 1.7× 646 1.4× 134 0.4× 498 1.8× 463 1.9× 101 2.2k
Maria Ornella Nicoletto Italy 18 496 0.9× 581 1.3× 85 0.3× 445 1.6× 324 1.3× 54 1.3k
Tomoyuki Nagai Japan 24 599 1.1× 528 1.2× 147 0.4× 73 0.3× 260 1.1× 95 1.7k
Yanling Feng China 19 324 0.6× 208 0.5× 124 0.4× 357 1.3× 170 0.7× 70 1.1k
Ryusuke Murakami Japan 19 606 1.1× 1.2k 2.8× 952 2.8× 450 1.6× 393 1.6× 78 2.3k

Countries citing papers authored by Yuji Ikeda

Since Specialization
Citations

This map shows the geographic impact of Yuji Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Ikeda more than expected).

Fields of papers citing papers by Yuji Ikeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuji Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Ikeda. The network helps show where Yuji Ikeda may publish in the future.

Co-authorship network of co-authors of Yuji Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Yuji Ikeda. A scholar is included among the top collaborators of Yuji Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuji Ikeda. Yuji Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobayashi, Osamu, et al.. (2024). Carcinogenesis and epidemiology of cervical cancer: The hallmark of human papillomavirus‐associated cancer. Journal of obstetrics and gynaecology research. 50(S1). 25–30. 1 indexed citations
2.
Katoh, Yuki, Akiko Kubo, Miho Iida, et al.. (2023). Serum Free Fatty Acid Changes Caused by High Expression of Stearoyl-CoA Desaturase 1 in Tumor Tissues Are Early Diagnostic Markers for Ovarian Cancer. Cancer Research Communications. 3(9). 1840–1852. 4 indexed citations
3.
Ikeda, Yuji, Sho Sato, Akira Yabuno, et al.. (2020). High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo. Journal of Gynecologic Oncology. 31(6). e93–e93. 10 indexed citations
4.
Hihara, Taro, Daisuke Shintani, Akira Yabuno, et al.. (2020). Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic <i>PIK3CA</i> or <i>KRAS</i> Mutations. Cancer Research and Treatment. 52(4). 1219–1228. 14 indexed citations
5.
Matsuda, Tatsuo, Matthias Leisegang, Jae‐Hyun Park, et al.. (2018). Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor–Engineered T Cells for Ovarian Cancer. Clinical Cancer Research. 24(21). 5357–5367. 67 indexed citations
6.
Yamasaki, Satoko, Yasuhisa Sakata, Hisako Yoshida, et al.. (2018). Shorter Relapse-Free Period after Leukocyte Removal Therapy in Younger than Older Patients with Ulcerative Colitis. Digestion. 100(4). 247–253. 4 indexed citations
7.
Zewde, Makda, Kazuma Kiyotani, Jae‐Hyun Park, et al.. (2018). The era of immunogenomics/immunopharmacogenomics. Journal of Human Genetics. 63(8). 865–875. 10 indexed citations
8.
Saloura, Vassiliki, Makda Zewde, Kazuma Kiyotani, et al.. (2017). Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck. Clinical Cancer Research. 23(16). 4897–4907. 20 indexed citations
9.
Ikeda, Yuji, Kazuma Kiyotani, Poh Yin Yew, et al.. (2017). Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer. Oncology Reports. 37(5). 2603–2610. 34 indexed citations
10.
Yabuno, Akira, Daisuke Shintani, Yuji Ikeda, et al.. (2017). Evaluation of circulating tumor DNA in patients with ovarian cancer harboring somatic PIK3CA or KRAS mutations. Annals of Oncology. 28. v336–v336. 17 indexed citations
11.
Ikeda, Yuji, Jae‐Hyun Park, Takashi Miyamoto, et al.. (2016). T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer. Clinical Cancer Research. 22(24). 6110–6117. 64 indexed citations
12.
Ikeda, Yuji, Ryo Kitagawa, Fuminori Ito, et al.. (2016). Practice patterns of adjuvant therapy for intermediate/high recurrence risk cervical cancer patients in Japan. Journal of Gynecologic Oncology. 27(3). e29–e29. 23 indexed citations
13.
Fukuda, Tomohiko, Katsutoshi Oda, Osamu Wada‐Hiraike, et al.. (2016). Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells. Oncology Letters. 12(4). 2560–2566. 39 indexed citations
14.
Matsuo, Koji, Kosei Hasegawa, Kiyoshi Yoshino, et al.. (2015). Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma. European Journal of Cancer. 51(14). 1978–1988. 46 indexed citations
15.
Ikeda, Yuji, Katsutoshi Oda, Hideki Ishihara, et al.. (2015). Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy. British Journal of Cancer. 113(10). 1477–1483. 23 indexed citations
16.
Ikeda, Yuji, et al.. (2015). Synchronous mucinous metaplasia and neoplasia of the female genital tract with external urethral meatus neoplasm: A case report. SHILAP Revista de lepidopterología. 12. 27–30. 6 indexed citations
17.
Oda, Katsutoshi, Yuji Ikeda, Daichi Maeda, et al.. (2014). Huge pyogenic cervical cyst with endometriosis, developing 13 years after myomectomy at the lower uterine segment: a case report. BMC Women s Health. 14(1). 104–104. 2 indexed citations
18.
Shoji, Keiko, Katsutoshi Oda, Shunsuke Nakagawa, et al.. (2010). Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: a case report. Medical Oncology. 28(3). 771–774. 20 indexed citations
19.
Amemori, Sadahiro, Ryuichi Iwakiri, Hiroyoshi Endo, et al.. (2006). Oral dimethyl sulfoxide for systemic amyloid A amyloidosis complication in chronic inflammatory disease: a retrospective patient chart review. Journal of Gastroenterology. 41(5). 444–449. 33 indexed citations
20.
Sakemi, Takanobu, et al.. (1998). End-Stage Renal Failure due to Crescentic Glomerulonephritis in a Patient with Behçet’s Syndrome. American Journal of Nephrology. 18(4). 321–324. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.G.J. van der Zee Breakdown of academic impact, for papers by Shulan Zhang Breakdown of academic impact, for papers by Muh‐Hwa Yang Breakdown of academic impact, for papers by Jesús González Bosquet Breakdown of academic impact, for papers by Eiichiro Tominaga Breakdown of academic impact, for papers by Ilan Bruchim Breakdown of academic impact, for papers by Maria Ornella Nicoletto Breakdown of academic impact, for papers by Tomoyuki Nagai Breakdown of academic impact, for papers by Yanling Feng Breakdown of academic impact, for papers by Ryusuke Murakami
Rankless by CCL
2026